GE HealthCare Technologies Inc.
Income Statement
| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $1.98B | $2.26B | $1.99B | $1.99B | $2.01B | $2.28B | $2.03B | $2.00B |
| Gross Margin | 38.5% | 39.7% | 38.7% | 39.6% | 42.1% | 42.8% | 41.7% | 41.4% |
| Operating Expenses | ||||||||
| Research & Development | $345.0M | $322.0M | $292.0M | $302.0M | $344.0M | $344.0M | $316.0M | $327.0M |
| SG&A Expense | $1.12B | $1.11B | $1.05B | $1.03B | $1.04B | $1.13B | $1.03B | $1.07B |
| Operating Income | $515.0M | $827.0M | $653.0M | $654.0M | $629.0M | $801.0M | $676.0M | $608.0M |
| Operating Margin | 10.0% | 14.5% | 12.7% | 13.1% | 13.2% | 15.1% | 13.9% | 12.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $505.0M | $820.0M | $643.0M | $613.0M | $692.0M | $833.0M | $658.0M | $578.0M |
| Income Tax Expense | $94.0M | $218.0M | $179.0M | $113.0M | $104.0M | $96.0M | $168.0M | $143.0M |
| Net Income | $389.0M | $588.0M | $446.0M | $486.0M | $564.0M | $721.0M | $470.0M | $428.0M |
| Net Margin | 7.6% | 10.3% | 8.7% | 9.7% | 11.8% | 13.6% | 9.7% | 8.8% |
| EPS (Basic) | $0.85 | $1.29 | $0.98 | $1.06 | $1.23 | $1.58 | $1.03 | $0.94 |
| EPS (Diluted) | $0.85 | $1.28 | $0.98 | $1.06 | $1.23 | $1.58 | $1.02 | $0.93 |
| Shares Outstanding (Basic) | 456.0M | 456.0M | 456.0M | 457.0M | 457.0M | 456.0M | 457.0M | 457.0M |
| Shares Outstanding (Diluted) | 457.0M | 458.0M | 457.0M | 458.0M | 459.0M | 459.0M | 459.0M | 459.0M |
| Dividends Per Share | $0.04 | — | $0.07 | — | $0.04 | $0.04 | $0.03 | $0.03 |